Timothy King Selected Research

Autoimmune Diseases (Autoimmune Disease)

12/2017

Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timothy King Research Topics

Disease

1	Brain Edema (Cerebral Edema) 04/2024
1	Hypoglycemia (Reactive Hypoglycemia) 04/2024
1	Hypokalemia 04/2024
1	Wounds and Injuries (Trauma) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Thyroid Neoplasms (Thyroid Cancer) 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 12/2017
1	Celiac Disease (Celiac Sprue) 12/2017
1	Headache (Headaches) 12/2017
1	Nausea 12/2017
1	Abdominal Pain (Pain, Abdominal) 12/2017
1	Insulin Resistance 10/2015

Drug/Important Bio-Agent (IBA)

2	Insulin (Novolin)FDA Link 04/2024 - 10/2015
1	Glucose (Dextrose)FDA LinkGeneric 04/2024
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2019
1	Nexvax2IBA 12/2017
1	EpitopesIBA 12/2017
1	Glutens (Glutelin)IBA 12/2017
1	Peptides (Polypeptides)IBA 12/2017
1	CytokinesIBA 12/2017
1	LipidsIBA 10/2015
1	Perilipin-5IBA 10/2015

Therapy/Procedure

1	Artificial Respiration (Mechanical Ventilation) 04/2024
1	Skin Transplantation (Skin Grafting) 01/2021
1	Immunotherapy 12/2017
1	Injections 12/2017
1	Gluten-Free Diet 12/2017